Pregnancy

Teladoc Health Expands Connected Care Partnerships

New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral…

10 months ago

Sidekick Health Expands Women’s Health Portfolio with Launch of MENO! App in a New Clinical Study

NEW YORK, March 10, 2025 /PRNewswire/ -- Sidekick Health, a leading digital health company, today announced the launch of a…

10 months ago

Philips and Ingeborg Initiatives address maternal health challenges in Arkansas with access to critical resources through the Philips Avent Pregnancy+ app

Arkansas moms get access to customized content and information on essential state resources for a healthier pregnancy CAMBRIDGE, Mass. &…

10 months ago

Philips and Ingeborg Initiatives address maternal health challenges in Arkansas with access to critical resources through the Philips Avent Pregnancy+ app

Arkansas moms get access to customized content and information on essential state resources for a healthier pregnancy CAMBRIDGE, Mass. &…

10 months ago

Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…

10 months ago

PACIFY LAUNCHES NEW, BEST-IN-CLASS MATERNAL HEALTH PLATFORM

Centered on personalizing the patient experience for expecting and new parents, Pacify is revolutionizing virtual care to drive better outcomes…

10 months ago

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management

VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March…

11 months ago

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection PRINCETON, N.J., March 3, 2025…

11 months ago

Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C

New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information…

11 months ago

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product…

11 months ago